electroCore to Engage with Investors at Upcoming Conferences
ROCKAWAY, N.J. — electroCore, Inc. (Nasdaq: ECOR), a pioneering company in bioelectronic medicine and wellness, is gearing up to participate in two significant investor conferences. This is an exciting opportunity for the company's management to engage with investors, share insights, and discuss advancements in their innovative products.
Details of the Notable Conferences
Management will attend the following conferences:
The Annual Roth Conference
Taking place from March 16 to March 18, this event will be held at the scenic Laguna Cliffs Marriott Resort & Spa. Joshua Lev, the Chief Financial Officer, will host one-on-one meetings, allowing investors to have personalized discussions that address their specific interests and inquiries about electroCore's strategic vision and financial health.
LSI USA '25 Conference
Following this, the company will also exhibit at the LSI USA '25 conference scheduled for March 17 to March 21 at the luxurious Waldorf Astoria Monarch Beach Resort. Here, Joshua Lev will be on hand to interact with attendees, further detailing electroCore’s mission and product offerings.
Opportunities for Investors
Participants in these events who are keen on scheduling meetings with management can reach out through their respective Roth or LSI representatives. Additionally, inquiries can be directed to the FNK IR team via email for detailed scheduling arrangements.
About the Roth Capital Partners Conference
The Annual ROTH Conference is renowned as one of the largest gatherings for small-cap companies nationwide. It features a dynamic format that includes company presentations, interactive Q&A sessions, and opportunities for executive management meetings. Investors can expect to engage with leadership from around 500 private and public companies across diverse growth sectors, including healthcare, technology, and more.
About LSI
LSI is comprised of a dedicated team of industry experts, media professionals, and event strategists who share a mission to enhance lives through groundbreaking medical technology. Their work spans domestic and international markets, showcasing the most promising innovations in the sector.
About electroCore, Inc.
At the forefront of bioelectronic medicine, electroCore, Inc. is committed to advancing health through its non-invasive vagus nerve stimulation (nVNS) technology platform. The company primarily focuses on the commercialization of medical devices designed for managing and treating various medical conditions, while also offering consumer products aimed at promoting overall wellbeing and enhancing human performance.
For those seeking more information about electroCore’s initiatives and products, they are encouraged to visit their official site.
Contact Information
For investor-related inquiries, reach out to:
ECOR Investor Relations
(973) 302-9253
For additional inquiries, contact investors@electrocore.com
Frequently Asked Questions
What is electroCore focused on?
electroCore is dedicated to the field of bioelectronic medicine and wellness, aiming to improve health through innovative technology.
When are the investor conferences?
The investor conferences will take place from March 16 to March 21, featuring various engagement opportunities.
Who will represent electroCore at these events?
Joshua Lev, the Chief Financial Officer, will represent electroCore, leading meetings and presentations during the conferences.
How can investors engage with management during the conferences?
Investors can schedule meetings with management through Roth or LSI representatives or by contacting FNK IR directly.
Where can I find more information about electroCore?
For additional details on products and initiatives, visit the official website of electroCore.
